BridgeBio Pharma, Inc.
BBIONasdaqCIK 1743881HealthcareFiscal year ends Dec 31
Reports and events: 183 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:52 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001743881-26-000034 |
| 2026-10-2916:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001743881-26-000033 |
| 2026-10-1306:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-039334 |
| 2026-08-3115:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-035055 |
| 2026-08-1717:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-033404 |
| 2026-08-1709:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-033282 |
| 2026-08-1016:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001743881-26-000027 |
| 2026-08-1016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001743881-26-000026 |
| 2026-07-2216:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-029291 |
| 2026-07-1019:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-26-003237 |
| 2026-07-0216:23 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-027445 |
| 2026-06-2608:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-026506 |
| 2026-05-2716:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-022979 |
| 2026-05-1316:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-021036 |
| 2026-05-0809:01 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-019761 |
| 2026-05-0716:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001743881-26-000019 |
| 2026-05-0716:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001743881-26-000018 |
| 2026-04-2416:25 ET | DEF 14A | Proxy statementPeriod 2026-06-22 | 0001140361-26-016723 |
| 2026-04-0218:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-26-001499 |
| 2026-03-3017:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-011991 |
| 2026-02-2416:51 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001743881-26-000009 |
| 2026-02-2416:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001743881-26-000008 |
| 2026-02-1720:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-26-000914 |
| 2026-02-1216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-004995 |
| 2026-01-2116:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-001843 |
| 2026-01-1216:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-000971 |
| 2025-11-1416:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-004059 |
| 2025-10-2916:57 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001743881-25-000012 |
| 2025-10-2916:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-039705 |
| 2025-10-2916:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001743881-25-000010 |
| 2025-10-2716:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-039463 |
| 2025-08-1420:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-003013 |
| 2025-08-0516:57 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103192 |
| 2025-08-0516:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102985 |
| 2025-07-0119:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-002298 |
| 2025-07-0217:42 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001140361-25-024413 |
| 2025-06-2316:29 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-023362 |
| 2025-05-1417:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-019024 |
| 2025-04-3006:01 ET | DEF 14A | Proxy statementPeriod 2025-06-20 | 0001140361-25-016452 |
| 2025-04-2917:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-060314 |
| 2025-04-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-060085 |
| 2025-03-1716:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-009063 |
| 2025-03-1216:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-000909 |
| 2025-03-0718:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-007701 |
| 2025-02-2816:11 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-006524 |
| 2025-02-2016:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-024119 |
| 2025-02-2007:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-023741 |
| 2025-01-3119:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-000308 |
| 2025-01-1316:53 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-000943 |
| 2024-11-2521:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-047704 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.